________________________________________________________
____EntRel____
500
3
____Arg1____
324..498
2
#### Text ####
A C$30-a-share bid by Ciba-Geigy Ltd., a pharmaceutical company based in Basel, Switzerland, and California-based Chiron Corp., a bioresearch concern, was extended to Nov. 16
##############
____Arg2____
500..540
3
#### Text ####
It had been due to expire Friday evening
##############
________________________________________________________
________________________________________________________
____Explicit____
552..562
4,1
#### Text ####
previously
##############
#### Features ####
Wr, Comm, Null, Null
previously, Temporal.Asynchronous.Succession
____Arg1____
135..156;252..320
1,0,0;1,0,1;1,0,3;1,1;1,2
#### Text ####
Institut Merieux S.A. said it would extend its bid, due to expire last Thursday, to Nov. 6
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
544..551;563..688
4,0;4,2;4,3
#### Text ####
Merieux said it would ensure its bid remained open pending a final decision by Canadian regulators on whether to approve the takeover
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____EntRel____
690
5
____Arg1____
544..688
4
#### Text ####
Merieux previously said it would ensure its bid remained open pending a final decision by Canadian regulators on whether to approve the takeover
##############
____Arg2____
690..805
5
#### Text ####
Merieux, a vaccine and bioresearch firm based in Lyon, France, is controlled 50.1% by state-owned Rhone Poulenc S.A
##############
________________________________________________________
________________________________________________________
____Explicit____
1091..1095
7,1,2,1,1,1,4,1,1,1,1,2,0
#### Text ####
once
##############
#### Features ####
Ot, Comm, Null, Null
998..1030
7,0;7,1,0;7,1,1;7,2
#### Text ####
Merieux officials said last week
##############
once, Temporal.Asynchronous.Succession, Contingency.Cause.Reason
____Arg1____
1064..1090
7,1,2,1,1,1,4,0;7,1,2,1,1,1,4,1,0;7,1,2,1,1,1,4,1,1,0;7,1,2,1,1,1,4,1,1,1,0;7,1,2,1,1,1,4,1,1,1,1,0;7,1,2,1,1,1,4,1,1,1,1,1
#### Text ####
the offer will be approved
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1096..1164
7,1,2,1,1,1,4,1,1,1,1,2,1
#### Text ####
it submits details of its proposed investments to federal regulators
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
1644
10
#### Features ####
Wr, Comm, Null, Null
while, Comparison.Contrast
____Arg1____
1392..1580
9,1,1
#### Text ####
that at the close of business Thursday, 5,745,188 shares of Connaught and C$44.3 million face amount of debentures, convertible into 1,826,596 common shares, had been tendered to its offer
##############
#### Features ####
Ot, Comm, Null, Null
1321..1391
9,0;9,1,0;9,2
#### Text ####
Institut Merieux, which already holds a 12.5% stake in Connaught, said
##############
____Arg2____
1644..1697
10,4,1
#### Text ####
11,580 common shares had been tendered to their offer
##############
#### Features ####
Ot, Comm, Null, Null
1582..1643
10,0;10,1;10,2;10,3;10,4,0;10,5
#### Text ####
At the close of business Thursday, Ciba-Geigy and Chiron said
##############
________________________________________________________
________________________________________________________
____Implicit____
1699
11
#### Features ####
Wr, Comm, Null, Null
while, Expansion.Conjunction
____Arg1____
1582..1697
10
#### Text ####
At the close of business Thursday, Ciba-Geigy and Chiron said 11,580 common shares had been tendered to their offer
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1699..1760
11
#### Text ####
At last report, Connaught had 21.8 million shares outstanding
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1764..1774
12,0
#### Text ####
Separately
##############
#### Features ####
Wr, Comm, Null, Null
separately, Expansion.Conjunction
____Arg1____
9..131
0
#### Text ####
Two rival bidders for Connaught BioSciences extended their offers to acquire the Toronto-based vaccine manufacturer Friday
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1776..1951
12,1;12,2;12,3;12,4
#### Text ####
the Ontario Supreme Court said it will postpone indefinitely a ruling on the lawsuit launched by the University of Toronto against Connaught in connection with the Merieux bid
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
